Drug · DIN 02521253
CEPHALEXIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 31, 2022; first marketed May 31, 2022.
- Drug Identification Number (DIN)
- 02521253
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Cefalexin J01DB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEPHALEXIN (CEPHALEXIN MONOHYDRATE) | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 18, 2021: NOC 26862New Drug Submission (NDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named CEPHALEXIN
- DIN 02495651 · Marketed
- DIN 02521261 · Marketed